Purpose Induced pluripotent stem (iPS) cells have been generated from mouse and human fibroblasts by several groups; however, transplanted mouse iPS cells can cause teratomas, depending on their tissue of origin. Therefore, human iPS cells are preferable, and various tissues are being evaluated for their potential to generate human iPS cells. Methods We examined whether adult human testicular tissue had undergone reprogramming by introducing four transcription factors, OCT4, SOX2, KLF4, and C-MYC, using lentiviral vectors. Results We obtained embryonic stem (ES)-like cells derived from human testicular tissue by introducing four cDNAs, encoding the transcription factors OCT4, SOX2, KLF4, and C-MYC, using lentiviral vectors. We showed that DAZL and VASA were expressed in testicular cells but down-regulated in ES-like cells, indicating that the cells had undergone reprogramming. ES-like cells could develop tumors, which is a hallmark of pluripotency, when SCID mice were injected with these cells. Conclusions We induced iPS cells from adult human testicular tissue by introducing four transcription factors, OCT4, SOX2, KLF4, and C-MYC, using lentiviral vectors. Future studies on these cells may elucidate the causes of male infertility, and eventually lead to treatments with autologous testicular tissue-derived iPS cells.
Introduction
Spermatogonial stem cells (SSCs) are self-renewing cells whose progeny are committed to differentiate into spermatozoa, a process that occurs throughout the life of male mammals [1] ; however, the mechanisms underlying the processes of SSC self-renewal and differentiation remain elusive. One approach to studying SSCs is to cultivate them in vitro under conditions that allow self-renewal and then induce their differentiation. For this purpose, a serum-free culture system for mouse SSCs was developed and used to evaluate the environmental factors required for their maintenance and replication [2] ; however, the study of human SSCs is much less advanced.
It was recently reported that introducing a set of transcription factors linked to pluripotency can directly reprogram human somatic cells to produce induced pluripotent stem (iPS) cells [3] [4] [5] [6] . In addition, pluripotent stem cells have been generated from adult human testis [7, 8] . An earlier study reported that the ES cell genes NANOG and OCT4, which encode transcription factors, are expressed in the normal testis [9] . In previous reports, we confirmed that cells derived from biopsied human testicular tissue express NANOG and OCT4, and obtained results suggesting that biopsied human testicular tissue might include human SSCs [10] . Furthermore, we hypothesized that testicular tissue is more suitable for making iPS cells than human dermal fibroblasts. In addition, because the injection of mouse iPS cells can lead to teratoma formation, depending on the tissue of origin, exploring human tissues other than dermal fibroblasts to determine their usefulness as iPS cell sources is important for advancing the use of these cells clinically as well as in research.
In this study, we obtained ES-like cells derived from human testicular tissue by introducing four cDNAs, encoding the transcription factors OCT4, SOX2, KLF4, and C-MYC, using lentiviral vectors. In the future, iPS cells derived from the testicular tissue of infertile men may help reveal the mechanisms of male infertility and lead to novel cell-based treatments. In addition, the examination of iPS cells derived from testicular tissue may elucidate the mechanisms of human SSC self-renewal and differentiation.
Materials and methods

Human subjects
The subjects were male patients being treated for infertility at the Reproduction Center of Toho Medical Center, Omori Hospital. In accordance with the regulations set out by the Human Investigations Committee of Toho University School of Medicine, informed consent was obtained from all of the subjects. Testicular tissue was obtained from two patients (Fig. 1a) . The first patient, who had azoospermia, underwent a testis biopsy as part of an evaluation for obstructive azoospermia. The hormone analysis (FSH, LH, testosterone) was normal. The second patient was being treated for a testis tumor; however, normal (i.e., nontumor) tissue was obtained from him for this study.
Adult human testis tissues
We confirmed the presence of mature sperm in the testicular tissue, which was used fresh. Cell suspensions from testis tissue were prepared by enzymatic digestion [11] . The dissociated testis cell suspensions were plated at 6.0 9 10 5 -4.5 9 10 6 cells per 0.1% gelatin (Sigma)-coated 10-cm culture dish with Dulbecco's modified Eagle medium (DMEM) (Invitrogen) containing 7% fetal bovine serum (FBS), 2 mM glutamine (Sigma), and antibiotics (50 U/ml penicillin and 50 lg/ml streptomycin; Sigma). The cells were incubated at 37°C in a humidified 5% CO 2 / 95% air atmosphere for 7-10 days.
Cell culture 293FT cells were purchased (Invitrogen), and maintained in a standard culture medium (DMEM supplemented with 7% FBS, 2 mM glutamine, 50 U/ml penicillin, and 50 lg/ml streptomycin). The mitomycin C-treated mouse embryonic fibroblast (MEF) feeder cells were purchased (ReproCELL), and plated in 0.1% gelatin-coated 10-cm culture dishes and maintained in standard culture medium. The ES-like cells were generated and maintained in Primate ES medium (ReproCELL) supplemented with 4 ng/ml recombinant human basic fibroblast growth factor (bFGF) (R&D Systems), and the medium was changed daily. For passaging, the ES-like cells were rinsed once with Hank's balanced salt solution (HBSS) (Invitrogen) and incubated with dissociation medium (ReproCELL) at 37°C. All cultures were maintained at 37°C in a humidified 5% CO 2 /95% air atmosphere.
Plasmid construction
The open reading frames of human OCT4, SOX2, KLF4, and C-MYC were amplified by reverse-transcription polymerase chain reaction (RT-PCR) and subcloned into pLenti 6.3/V5-TOPO (Invitrogen). A stop codon was inserted after each gene to avoid expressing the V5 tag. The plasmids were constructed by Invitrogen.
Lentivirus production and infection
The ViraPower TM HiPerfome TM Lentiviral Expression Kit (Invitrogen) was used to produce lentiviruses. 293FT cells were plated at 6 9 10 6 cells per 10-cm dish and incubated overnight. We prepared four dishes of 293FT cells to produce each of the four lentiviruses (encoding OCT4, SOX2, KLF4, and C-MYC). The next day, the 293FT cells were transfected with 3 lg pLenti 6.3/V5-TOPO and 9 lg ViraPower packaging mix with the Fugene 6 transfection reagent (Roche), following the manufacturer's instructions. Twenty-four hours after transduction, the medium was collected as the first virus-containing supernatant and replaced with new medium. Forty-eight hours after transduction, the medium was collected as the second viruscontaining supernatant and replaced with new medium. Seventy-two hours after transduction, the medium was collected as the third virus-containing supernatant. The virus-containing supernatant was filtered through a 0.45-lm poresize filter (Millipore). After each transduction period, equal amounts of supernatant containing each of the four lentiviruses were mixed, and then transferred to the dissociated testis cell suspension. For this, the medium containing the dissociated testis cell suspension was first collected in 15-ml conical tubes, spun, and the supernatant was aspirated. The cells were then replated onto 10-cm plates with the virus-containing supernatant, and incubated at 37°C.
ES-like cell generation
Twenty-four hours after the third transduction of the testes cell suspension, the virus-containing medium was replaced with standard culture medium. The medium was changed every day. Five to 6 days after the third transduction, the cells were harvested by trypsinization and plated on MEF feeder cells at 5 9 10 4 cells per 10-cm dish, with Primate ES cell medium supplemented with 4 ng/ml bFGF. The medium was changed every day. The ES-like cell colonies were picked 21-25 days after the transduction and transferred into 0.5 ml of Primate ES cell medium. The colonies were mechanically dissociated into small clumps. The dissociated cells were transferred to MEF feeder cells in 24-well plates.
Immunofluorescence microscopy and immunostaining
The Human Embryonic Stem Cell Marker Antibody Panel was used (R&D Systems). Cells were washed twice with phosphate-buffered saline, fixed with 4% (w/v) paraformaldehyde for 20 min, permeabilized for 60 min with phosphate-buffered saline containing 0.1% (v/v) Triton X-100, and then blocked for 3 h with phosphate-buffered saline containing 20% donkey serum. For immunostaining, the fixed samples were incubated with an anti-human alkaline phosphatase monoclonal antibody, anti-human NANOG polyclonal antibody, anti-human OCT4 polyclonal antibody, anti-human SSEA-1 monoclonal antibody, and anti-human SSEA-4 monoclonal antibody (all R&D Systems) as indicated, washed three times with phosphatebuffered saline containing 0.1% (v/v) Triton X-100, and probed with the appropriate secondary antibodies (antigoat IgG antibody conjugated with Alexa 488 and antimouse IgG antibody conjugated with Alexa 488 (Molecular Probes)). Immunostaining of nucleic acid was performed using SYTOX Ò Orange nucleic acid stain (Molecular Probes).
Reverse-transcription (RT)-PCR
Total RNA was prepared using the PureLink TM Micro-toMidi Total RNA Purification System (Invitrogen). RT Short tandem repeat (STR) analysis and karyotyping DNA fingerprinting analyses with STR markers and chromosomal G-band analyses were performed at SRL Laboratory.
In vitro assay (embryoid body formation)
Confluent ES-like cells in a 10-cm dish were harvested by trypsinization. The iPS cells were transferred to a poly (hydroxyethyl methacrylate-co-methyl methacrylate; HEMA-MMA)-coated dish in Primate ES cell medium. The medium was changed every other day, and the cells were maintained in floating culture for 8 days.
In vivo assay (teratoma formation) Confluent ES-like cells in a 6-well dish were harvested by trypsin treatment, collected into tubes, spun, and the pellets were suspended in Primate ES cell medium. The cells were then injected into the testes of 8-week-old SCID mice (Charles River). Twelve weeks later, the resulting teratomas were analyzed by SRL Laboratory.
Results
Generation of ES-like cells from human adult testicular tissue
Colonies with a human ES cell-like morphology first became visible in both samples 1 (Fig. 1b) and 2 (Fig. 1c) 15-16 days after transduction. We picked colonies 21-25 days after transduction. These ES cell-like colonies expanded on MEF feeder cells in Primate ES cell medium containing bFGF, and maintained a morphology similar to that of human ES cells. We confirmed about 20 ES cell-like colonies from 5 9 10 4 testicular cells from the two samples (data not shown). The efficiency of the formation of ES cell-like colonies was 0.04%. Confirmation by STR analysis and normal karyotype that the ES cell-like colonies were derived from human testicular tissue
We next evaluated the samples to confirm that the colonies were derived from testicular tissue. The patterns of 16 STRs matched completely between the ES cell-like colonies and the testicular tissue in the two samples. We indicated a pattern of 8 STRs between the ES cell-like colonies and testicular tissue (Fig. 1d, e) . These findings showed that the ES cell-like colonies were obtained from testicular tissues and were not the result of cross-contamination.
In addition, a chromosomal G-band analysis of the colonies showed a normal karyotype of 46 chromosomes, including X and Y, in the ES-like cells of both samples (Fig. 2) .
The ES cell-like colonies express human ES cell markers by immunostaining
We next characterized the newly-established ES-like cells by immunostaining. For this analysis, we used the ES-like cells derived from sample 2. The ES-like cells did not express stage-specific embryonic antigen (SSEA-1) (Fig. 3d) , but they did express human ES cell-specific proteins, including alkaline phosphatase, NANOG, OCT4, and the surface antigen SSEA-4 ( Fig. 3a-c, e) .
Reprogramming of human testicular cells
RT-PCR showed that our testicular tissue-derived ES-like cells expressed many undifferentiated ES cell marker (Fig. 4) . We confirmed that the two testicular tissue samples expressed OCT4, NANOG, STELLAR, DAZL, and VASA (data not shown). We found that DAZL and VASA were expressed in the testis cell suspensions, but not in the ES-like cells (Fig. 4) .
Pluripotency of the ES cell-like colonies derived from human testicular tissue One of the easiest procedures for eliciting the in vitro differentiation of ES cells is to allow them to form embryoid bodies in floating culture. After 8 days in floating culture, the ES-like cells derived from sample 2 had formed embryoid bodies (Fig. 5a) . To test the pluripotency of ES-like cells in vivo, we injected them into the testes of SCID mice. Twelve weeks later, histological inspection showed that the differentiated aggregates contained muscle tissue (mesoderm), neural tissue (ectoderm), and gut-like structures (endoderm) (Fig. 5b) .
Discussion
Male infertility has become an increasing health and social concern worldwide, and new treatment options are needed. For example, one particularly problematic form of male infertility is nonobstructive azoospermia, which is typically seen in men with small-volume testes and elevated folliclestimulating hormone (FSH). Men with this condition have severely deficient spermatogenesis, and cannot father children. Currently, they must consider donor insemination or adoption if they want to have children. The main treatment for nonobstructive azoospermia is microdissection testicular sperm extraction (micro-TESE), which has an unsatisfactory success rate [13] .
Human iPS cells derived from various tissues, including skin fibroblasts [3, 4, 6] , keratinocytes [14] , and peripheral blood cells [15] have been reported. There are many differences among the reprogramming methods reported to date, and the safety and therapeutic implications of these methods need to be thoroughly evaluated before iPS cells can be used in cell therapies [16] . This is the first report of reprogramming of adult human testicular cells.
We have been interested in the possibility that the generation of iPS cells derived from the testicular tissues of Recently, the establishment of pluripotent stem cells from the adult human testis in vitro was reported [7, 8] . In addition, using 1 g of testicular tissue, Golestaneh et al.
[17] generated ES-like cells derived from the adult human testes. This result suggested that human SSCs were converted to ES-like cells; however, it is difficult to perform a 1-g biopsy in male patients with infertility or small testes. In male patients with infertility, the best way to produce human pluripotent stem cells is the reprogramming of adult human testicular cells. We therefore thought that testicular tissues would be a suitable material for generating iPS cells from biopsy samples, even though testicular tissue is difficult to obtain and the amount can be limited in men with infertility. Fortunately, our findings indicate that testis tissue can be a useful source of iPS cells.
The efficiency of the formation of ES-like colonies was 0.04%. Although this was low, it was about the same as the reported efficiency of iPS cell colonies generated from human dermal fibroblasts (*10 from 5 9 10 4 cells) [3] . Our reprogramming of human testicular cells into ES-like cells was successful. Human ES cells are reported to express OCT4, NANOG, and STELLAR [18, 19] , which are also expressed in the primordial germ cells (PGCs), gonocytes, and spermatogonia [18, [20] [21] [22] [23] . DAZL is expressed in fetal gonocytes and male germ cells at all stages of maturation, i.e., in the spermatogonia, spermatocytes, and spermatids [24] . Furthermore, human ES cells express DAZL mRNA and protein, but it is not expressed in the inner cell mass of human blastocytes [19] . PGCs begin to express VASA as they enter the genital ridges, and VASA continues to be expressed in the gonocytes, spermatogonia, and spermatocytes, but it is down-regulated in the spermatids [25] . Thus, our results show that adult human testicular cells had been reprogrammed by the introduction of the four transcription factors, OCT4, SOX2, KLF4, and C-MYC. During the reprogramming of mouse fibroblasts, the expression of cell type-specific markers changes in a sequential pattern: the fibroblast-specific marker Thy-1 is down-regulated [26] , and the ES cellspecific marker alkaline phosphatase is then up-regulated [27] .
Testis tissues contain SSCs, whose progeny ultimately produce spermatozoa. Although it is difficult to propagate human SSCs in vitro, the differentiation of germ cells from iPS cells may be achievable by using iPS technology in the near future. In addition, the direct differentiation of SSCs from iPS cells may be possible by using the appropriate reprogramming conditions. We conclude that iPS cells derived from adult human testicular tissue have great potential for use in clinical applications, and for research into the mechanisms of male infertility. Future advances may permit spermatids to be differentiated from testicular tissue-derived iPS cells, which might also be useful for clinical applications. Notably, using our present technique, the lentivirus used for gene delivery will integrate into the genome, regardless of the retrovirus used and the number of genes introduced. Therefore, improvement in the gene delivery system will be important for the successful generation of iPS cells for clinical applications.
